{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:37Z","timestamp":1761513217346},"reference-count":19,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1006,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/ane.12044","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:24:11Z","timestamp":1354188251000},"page":"11-15","source":"Crossref","is-referenced-by-count":24,"special_numbering":"supplement s196","title":["Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine"],"prefix":"10.1155","volume":"127","author":[{"given":"S.","family":"Svalheim","sequence":"first","affiliation":[{"name":"Department of Neurology; Oslo University Hospital - Rikshospitalet; Oslo; Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Department of Neurology; Oslo University Hospital - Rikshospitalet; Oslo; Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mochol","sequence":"additional","affiliation":[{"name":"Department of Neurology; \u00d8stfold County Hospital, Fredrikstad, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Luef","sequence":"additional","affiliation":[{"name":"Department of Neurology; Medical University Innsbruck; Innsbruck; Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rauchenzauner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Saint Vincent Hospital Zams; Zams; Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S.","family":"Fr\u00f8land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Taub\u00f8ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"10.1111\/ane.12044-BIB0001|ane12044-cit-0001","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(71)90547-2","article-title":"Depression of immunological function in patients treated with phenytoin sodium (diphenylhydantoin)","volume":"4","author":"Sorrell","year":"1971","journal-title":"Lancet"},{"key":"10.1111\/ane.12044-BIB0002|ane12044-cit-0002","first-page":"273","article-title":"Depression of immune competence by phenytoin and carbamazepine","volume":"20","author":"Sorrell","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ane.12044-BIB0003|ane12044-cit-0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","article-title":"Serum immunoglobulins and risk of infection: how low can you go?","volume":"39","author":"Furst","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/ane.12044-BIB0004|ane12044-cit-0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00313318","article-title":"The reversibility of phenytoin-induced IgA deficiency","volume":"226","author":"Gilhus","year":"1981","journal-title":"J Neurol"},{"key":"10.1111\/ane.12044-BIB0005|ane12044-cit-0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/00365540260348662","article-title":"Reversible panhypogammaglobulinemia associated with phenytoin treatment","volume":"34","author":"Pereira","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/ane.12044-BIB0006|ane12044-cit-0006","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0192-0561(94)90087-6","article-title":"Humoral and cellular immune parameters in untreated and phenytoin or carbamazepine treated epileptic patients","volume":"16","author":"Basaran","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"10.1111\/ane.12044-BIB0007|ane12044-cit-0007","first-page":"269","article-title":"Effect of anti-epileptic drugs on serum level of IgG subclasses","volume":"20","author":"Ashrafi","year":"2010","journal-title":"Iran J Pediatr"},{"key":"10.1111\/ane.12044-BIB0008|ane12044-cit-0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0404.1982.tb04514.x","article-title":"The effect of carbamazepine on serum immunoglobulin concentrations","volume":"66","author":"Gilhus","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12044-BIB0009|ane12044-cit-0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1986.tb07852.x","article-title":"Carbamazepine effects on mononuclear blood cells in epileptic patients","volume":"74","author":"Gilhus","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12044-BIB0010|ane12044-cit-0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S0041-87812001000600006","article-title":"Secondary hypogammaglobulinemia after use of carbamazepine: case report and review","volume":"56","author":"Castro","year":"2001","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"10.1111\/ane.12044-BIB0011|ane12044-cit-0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1081-1206(10)60846-0","article-title":"Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam","volume":"101","author":"Azar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/ane.12044-BIB0012|ane12044-cit-0012","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11319450-000000000-00000","article-title":"Pancytopenia associated with levetiracetam treatment","volume":"29","author":"Gallerani","year":"2009","journal-title":"Clin Drug Invest"},{"key":"10.1111\/ane.12044-BIB0013|ane12044-cit-0013","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/01.WNL.0000113754.29225.5D","article-title":"Lamotrigine-induced common variable immune deficiency","volume":"62","author":"Smith","year":"2004","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1111\/ane.12044-BIB0014|ane12044-cit-0014","first-page":"1","article-title":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological societies","volume":"118","author":"Rosen","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ane.12044-BIB0015|ane12044-cit-0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","article-title":"Common variable immunodeficiency: a review","volume":"3","author":"Di Renzo","year":"2004","journal-title":"Clin Exp Med"},{"key":"10.1111\/ane.12044-BIB0016|ane12044-cit-0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2249.2003.02097.x","article-title":"Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood","volume":"132","author":"Callenbach","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ane.12044-BIB0017|ane12044-cit-0017","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0404.1988.tb03671.x","article-title":"Immunological studies in focal epilepsy","volume":"78","author":"Eeg-Olofsson","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12044-BIB0018|ane12044-cit-0018","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(76)91028-X","article-title":"IgA deficiency, epilepsy, and hydantoin medication","volume":"2","author":"Fontana","year":"1976","journal-title":"Lancet"},{"key":"10.1111\/ane.12044-BIB0019|ane12044-cit-0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-3083.1995.tb03555.x","article-title":"A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome","volume":"41","author":"Van Engelen","year":"1995","journal-title":"Scand J Immunol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12044","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12044\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:51:13Z","timestamp":1671540673000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1111\/ane.12044","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}